Business Context and Reporting Period
Company: New Horizon Aircraft Ltd.
Filing Type: Form 8-K (Current Report)
Date of Report: June 27, 2025
Reporting Period: Single event date (June 27, 2025)
Business Context: The Company, an emerging growth company incorporated in British Columbia, operates in the aircraft sector and is listed on The Nasdaq Stock Market LLC under the symbols HOVR (Class A Ordinary Shares) and HOVRW (Warrants).
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The document focuses exclusively on a capital raising event.
- Capital on Demand Program: The Company increased the maximum aggregate offering price under its Sales Agreement with JonesTrading Institutional Services LLC.
- Additional Offering Capacity: $16,500,000 in Class A Ordinary Shares.
- Prior Sales under Agreement: $5,114,868 of Common Shares sold to date (as of June 27, 2025).
- Warrant Exercise Price: $11.50 per share.
Material Changes
The primary material change reported is the expansion of the Company's equity financing capacity.
- Event: Filing of a prospectus supplement to increase the aggregate offering price available under the existing Capital on Demand Sales Agreement.
- Impact: The Company can now issue up to an additional $16.5 million in shares, separate from the $5.1 million already sold under the agreement dated February 14, 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, earnings outlook, or management discussion regarding operational strategy beyond the execution of the capital raise.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies. However, the increase in share issuance capacity implies potential dilution to existing shareholders if the additional shares are sold.
Unusual Items: None reported beyond the routine expansion of an at-the-market equity offering program.
Investor Verification Checklist
- Verify the total number of shares authorized for issuance under the updated Sales Agreement to assess potential dilution.
- Review the filed prospectus supplement (referenced in Item 8.01) for specific terms, pricing mechanisms, and underwriting fees associated with the additional $16.5 million.
- Confirm the current market price of HOVR relative to the $11.50 warrant exercise price to evaluate the likelihood of warrant exercise.
- Check subsequent filings to determine if and when the Company elects to sell shares under the newly increased capacity.